CN Patent

CN115165838B — 基于拉曼光谱和血清代谢构建mds和aml鉴别模型的方法和试剂盒

Assigned to Tianjin Medical University General Hospital · Expires 2025-09-30 · 1y expired

What this patent protects

本发明提供了一种基于拉曼光谱和血清代谢构建骨髓异常增生综合征(MDS)和急性髓细胞白血病(AML)鉴别模型、模型构建方法和试剂盒。本发明所述的鉴别模型，综合了血清学检测数据和拉曼光谱分析，为MDS和AML的快速早期鉴别提供了重要手段。

USPTO Abstract

本发明提供了一种基于拉曼光谱和血清代谢构建骨髓异常增生综合征(MDS)和急性髓细胞白血病(AML)鉴别模型、模型构建方法和试剂盒。本发明所述的鉴别模型，综合了血清学检测数据和拉曼光谱分析，为MDS和AML的快速早期鉴别提供了重要手段。

Drugs covered by this patent

Patent Metadata

Patent number
CN115165838B
Jurisdiction
CN
Classification
—
Expires
2025-09-30
Drug substance claim
No
Drug product claim
No
Assignee
Tianjin Medical University General Hospital
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.